SCHEMBL4725228

SCHEMBL4725228

CCn1c2ccccc2c2cc(NC(=O)CCN3CCC(Cc4ccccc4)CC3)ccc21

nearest known ligand 0.74

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 7/20 0.74
KDM4E B2RXH2 4/20 0.62
MAPT P10636 3/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
LMNA P02545 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA9 Q16790 1/20 0.58
USP2 O75604 1/20 0.57
RORC P51449 2/20 0.56
ALDH1A1 P00352 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4725717 0.88 NPY5R (0.78) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4727555 0.85 NPY5R (0.71) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4725105 0.85 NPY5R (1.00) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4727182 0.85 NPY5R (0.76) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4725755 0.84 NPY5R (0.98) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4727132 0.83 NPY5R (0.80) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL7722806 0.83 NPY5R (0.74) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4725128 0.83 NPY5R (0.79) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4727570 0.82 NPY5R (1.00) NPY5RKDM4EMAPTMEN1KMT2A
SCHEMBL4727176 0.81 NPY5R (0.80) NPY5RKDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021745-A2 HEPATITIS C VIRUS ENTRY INHIBITORS ITHERX PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed
US-6399631-B1 3-AMIDO OR 3-SULFONAMIDO; EATING DISORDERS IN HUMANS, DOGS AND CATS PFIZER INC. 2002-06-04 US disclosed